Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

The More You Take It, the Better It Works: Six-Month Results of a Nalmefene Phase-IV Trial.

Barrio P, Roncero C, Ortega L, Guardia J, Yuguero L, Gual A.

J Clin Med. 2019 Apr 6;8(4). pii: E471. doi: 10.3390/jcm8040471.

2.

Identifying Triggers of Alcohol Craving to Develop Effective Virtual Environments for Cue Exposure Therapy.

Ghiţă A, Teixidor L, Monras M, Ortega L, Mondon S, Gual A, Paredes SM, Villares Urgell L, Porras-García B, Ferrer-García M, Gutiérrez-Maldonado J.

Front Psychol. 2019 Jan 29;10:74. doi: 10.3389/fpsyg.2019.00074. eCollection 2019.

3.

Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: Impact on alcohol relapse.

López-Pelayo H, Miquel L, Altamirano J, Bataller R, Caballeria J, Ortega L, Lligoña A, Gual A.

J Psychosom Res. 2019 Jan;116:75-82. doi: 10.1016/j.jpsychores.2018.11.020. Epub 2018 Nov 28.

PMID:
30654998
4.

A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?

Barrio Giménez P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Adicciones. 2018 Jul 13;0(0):1046. doi: 10.20882/adicciones.1046. [Epub ahead of print] English, Spanish.

5.

Reply to Braillon et al.: Nalmefene Phase IV Study: A Seeding Flying in the Face of Evidence?

Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Clin Drug Investig. 2018 Apr;38(4):387-388. doi: 10.1007/s40261-018-0625-5. No abstract available.

PMID:
29480453
6.

Effectiveness of a Specialized Brief Intervention for At-risk Drinkers in an Emergency Department: Short-term Results of a Randomized Controlled Trial.

Bruguera P, Barrio P, Oliveras C, Braddick F, Gavotti C, Bruguera C, López-Pelayo H, Miquel L, Segura L, Colom J, Ortega L, Vieta E, Gual A.

Acad Emerg Med. 2018 May;25(5):517-525. doi: 10.1111/acem.13384. Epub 2018 Apr 2.

7.

Filling the gap between lab and clinical impact: An open randomized diagnostic trial comparing urinary ethylglucuronide and ethanol in alcohol dependent outpatients.

Barrio P, Teixidor L, Ortega L, Lligoña A, Rico N, Bedini JL, Vieta E, Gual A.

Drug Alcohol Depend. 2018 Feb 1;183:225-230. doi: 10.1016/j.drugalcdep.2017.11.015. Epub 2017 Dec 27.

PMID:
29291550
8.

Who Receives Nalmefene and How Does It Work in the Real World? A Single-Arm, Phase IV Study of Nalmefene in Alcohol Dependent Outpatients: Baseline and 1-Month Results.

Barrio P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.

Clin Drug Investig. 2018 Feb;38(2):147-155. doi: 10.1007/s40261-017-0590-4.

PMID:
29080208
9.

Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival.

Altamirano J, López-Pelayo H, Michelena J, Jones PD, Ortega L, Ginès P, Caballería J, Gual A, Bataller R, Lligoña A.

Hepatology. 2017 Dec;66(6):1842-1853. doi: 10.1002/hep.29338.

PMID:
28646515
10.

Patients' Knowledge and Attitudes Towards Regular Alcohol Urine Screening: A Survey Study.

Barrio P, Teixidor L, Ortega L, Balcells M, Vieta E, Gual A.

J Addict Med. 2017 Jul/Aug;11(4):300-307. doi: 10.1097/ADM.0000000000000315.

PMID:
28358755
11.

One Year Clinical Correlates of EtG Positive Urine Screening in Alcohol-Dependent Patients: A Survival Analysis.

Barrio P, Mondon S, Teixidor L, Ortega L, Vieta E, Gual A.

Alcohol Alcohol. 2017 Jul 1;52(4):460-465. doi: 10.1093/alcalc/agx012.

PMID:
28340031
12.

Self-management and Shared Decision-Making in Alcohol Dependence via a Mobile App: a Pilot Study.

Barrio P, Ortega L, López H, Gual A.

Int J Behav Med. 2017 Oct;24(5):722-727. doi: 10.1007/s12529-017-9643-6.

PMID:
28236288
13.

Remediation therapy in patients with alcohol use disorders and neurocognitive disorders: A Pilot Study.

Frías-Torres C, Moreno-España J, Ortega L, Barrio P, Gual A, Teixidor López L.

Adicciones. 2018 Apr 15;30(2):93-100. doi: 10.20882/adicciones.757. English, Spanish.

14.

Urine Ethyl Glucuronide Unraveling the Reality of Abstinence Monitoring in a Routine Outpatient Setting: A Cross-Sectional Comparison with Ethanol, Self Report and Clinical Judgment.

Barrio P, Teixidor L, Rico N, Bruguera P, Ortega L, Bedini JL, Gual A.

Eur Addict Res. 2016;22(5):243-8. doi: 10.1159/000445741. Epub 2016 May 26.

PMID:
27220985
15.

Alcohol in Primary Care. Differential characteristics between alcohol-dependent patients who are receiving or not receiving treatment.

Barrio P, Miquel L, Moreno-España J, Martínez A, Ortega L, Teixidor L, Manthey J, Rehm J, Gual A.

Adicciones. 2016 Mar 2;28(2):116-22. doi: 10.20882/adicciones.779. English, Spanish.

16.

Development, Validation, and Implementation of an Innovative Mobile App for Alcohol Dependence Management: Protocol for the SIDEAL Trial.

Barrio P, Ortega L, Bona X, Gual A.

JMIR Res Protoc. 2016 Feb 17;5(1):e27. doi: 10.2196/resprot.5002.

17.

[Detection and prevalence of alcohol use disorders in primary health care in Catalonia].

Miquel L, Barrio P, Moreno-España J, Ortega L, Manthey J, Rehm J, Gual A.

Aten Primaria. 2016 Mar;48(3):175-82. doi: 10.1016/j.aprim.2015.04.006. Epub 2015 Oct 9. Spanish.

18.

Psychiatric Comorbidity in Treatment-Seeking Alcohol Dependence Patients With and Without ADHD.

Roncero C, Ortega L, Pérez-Pazos J, Lligoña A, Abad AC, Gual A, Sorribes M, Grau-López L, Casas M, Daigre C.

J Atten Disord. 2015 Aug 12. pii: 1087054715598841. [Epub ahead of print]

PMID:
26269096
19.

Adult ADHD screening in alcohol-dependent patients using the Wender-Utah Rating Scale and the adult ADHD Self-Report Scale.

Daigre C, Roncero C, Rodríguez-Cintas L, Ortega L, Lligoña A, Fuentes S, Pérez-Pazos J, Martínez-Luna N, Casas M.

J Atten Disord. 2015 Apr;19(4):328-34. doi: 10.1177/1087054714529819. Epub 2014 Apr 17.

PMID:
24743975
20.

[Alcoholic patients hospitalized in a psychiatry unit: mortality at 14 years].

Monrás M, Ortega L.

Adicciones. 2011;23(4):317-25. Spanish.

Supplemental Content

Loading ...
Support Center